Comparison of hepatitis C vi̇rus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels;Hepati̇t C vi̇rus (HCV) RNA ve anti̇-HCV sonuçlarinin karşilaştirilmasi ve transami̇naz düzeyleri̇yle i̇li̇şki̇leri̇ni̇n deǧerlendi̇ri̇ lmesi̇

Mikrobiyoloji Bulteni

Volumn 41, Issue 4, 2007, Pages 557-563

  Kaşifoǧlu, Nilgün ^a   Us, Tercan ^a   Akgün, Yurdanur ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Anti HCV; HCV RNA; Real time reverse transcriptase polymerase chain reaction; Transaminases

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; RETROSPECTIVE STUDY;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 48849109113     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hanuka N, Sikuler E, Tovbin D, et al. Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Viral Hepat 2002; 9:141-5.
2. Gökahmetoǧlu S, Aygen B, Gürsoy Ş ve ark. Anti-HCV pozitif hastalarda HCV RNA varliǧinin deǧerlendirilmesi. Viral Hepatit Derg 2002; 1: 444-6.
3. Türkoǧlu S. HCV İnfeksiyonu: Viroloji ve Seroloji, s: 182-192. Kiliçturgay K, Badur S (ed), Viral Hepatit 2001. 2001, 1. baski. Viral Hepatitle Savaşim Derneǧi, İstanbul.
4. Us T, Akgün Y, Kural M. RT-PCR ve üçüncü kuşak ELISA yöntemleri ile saptanan HCV RNA ve anti-HCV sonuçlarinin karşilaştirilmasi. Viral Hepatit Derg 2001; 2: 298-301.
5. Di Biceqlie AM. Hepatitis C. Lancet 1998; 251: 351-5.
6. Çolak D, Öǧünç D, Gültekin M ve ark. Hepatit C virus (HCV) enfeksiyonu tanisinda enzim immunoassay (EIA), immunoblot (IB) ve polimeraz zincir reaksiyonu (PCR) yöntemlerinin karşilaştirilmasi. Viral Hepatit Derg 1998; 1: 5-8.
7. Sönmez E, Kizilkaya N, Taşyaran MA ve ark. Hepatit C virusu RNA pozitifliǧinin karaciǧer fonksiyon testleri ile ilişkisi. Klimik Derg 1996; 9:44-6.
8. Freucht HH, Zöllner B, Polywka S, Laufs R. Study on reliability of commercially available hepatitis C virus antibody tests. J Clin Microbiol 1995; 33: 620-4.
9. th ed. Churchill Livingstone, New York.
10. el-Sayed Zaki M, el-Adrosy H. Recent approach for diagnosis of early HCV infection. Egypt J Immunol 2004; 11: 123-9.
11. Castillo I, Pardo M, Bartolome J, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189: 7-14.
12. Sönmez E, Troisi C, Hollinger FB, et al. Screening of blood donors for HCV RNA by RT-PCR. Journal of Turgut Özal Medical Center 1996; 3: 303-5.
13. Forcic D, Zgorelec R, Branovic K, et al. Incidence of hepatitis C virus RNA in anti-HCV negative plasma pools in Croatia. Transfus Apher Sci 2001; 24: 269-78.
14. Rumi MG, Colombo M, Gringeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann Intern Med 1990; 112: 379-80.
15. Ghany MG, Chan TM, Sanchez-Pescador R, et al. Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection. Dig Dis Sci 1996; 41: 2213-8.
16. Leone N, Rizzetto M. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol 2005; 51: 31-46.
17. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36 (Suppl 1): S21-9.
18. Alberti A, Noventa F, Benvegnú L, et al. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med 2002; 137: 961-4.
19. Silini E, Bono F, Cerino A, et al. Virological features of hepatitis C virus infection in hemodialysis patients. J Clin Microbiol 1993; 31: 2913-7.